Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-96.83	15.30	-482.14
Graham Fair Price	41.42	0.87	0.61
PEG	-47.45	0.04	-0.08
Price/Book	-5.73	0.65	0.69
Price/Cash Flow	-22.59	22.05	28.48
Prices/Earnings	-52.87	4.02	8.53
Price/Sales	-52.87	6.63	14.07
Price/FCF	-22.59	22.05	28.48
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-47.25	0.53	1.00
Operating Margin	163.68	1.26	0.48
ROA	100.00	0.02	< 0.005
ROE	0.02	0.04	100.00
ROIC	0.01	0.18	1202.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.35	-0.30	14.46
Dividends QOQ	< 0.005	< 0.005	-95.12
EBIT QOQ	1.26	4.27	240.25
EPS QOQ	1.12	1.00	-10.31
FCF QOQ	-0.28	0.22	-22.35
Revenue QOQ	-0.51	1.00	94.40
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	4.97	100.00
Days Sales Outstanding (DSO)	0.00	3.45	100.00
Inventory Turnover	0.00	18.12	100.00
Debt/Capitalization	0.48	0.58	20.77
Quick Ratio	3.36	1.66	-50.74
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.91	0.91	< 0.005
Cash	0.05	0.02	-63.40
Capex	0.00	0.00	0.00
Free Cash Flow	0.02	0.03	21.77
Revenue	0.04	0.09	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.36	1.66	-50.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-271.29	10.06	-96.29
Naive Interpretation	Member

06 - Financial Health · Weak

Rating